Introduction:
The pharmaceutical industry in Indonesia has been experiencing steady growth in recent years, with an increasing focus on generic drug procurement and tenders. According to recent data, Indonesia’s pharmaceutical market is estimated to be worth over $10 billion, with a significant portion of this coming from government procurement. This report highlights the top 10 generic drug government procurement and tender agencies in Indonesia, showcasing the key players in the market.
Top 10 Generic Drug Government Procurement & Tender Agencies in Indonesia:
1. PT Kimia Farma Tbk
– Market share: 25%
– PT Kimia Farma Tbk is one of the largest pharmaceutical companies in Indonesia, specializing in the production of generic drugs. With a strong focus on government tenders, the company has secured a significant market share in the industry.
2. PT Kalbe Farma Tbk
– Market share: 20%
– PT Kalbe Farma Tbk is another major player in the Indonesian pharmaceutical market, known for its wide range of generic drug offerings. The company has been successful in securing government procurement contracts, further solidifying its position in the industry.
3. PT Indofarma Tbk
– Market share: 15%
– PT Indofarma Tbk is a key player in the generic drug market in Indonesia, with a strong presence in government tenders. The company’s focus on quality and affordability has helped it maintain a significant market share in the industry.
4. PT Tempo Scan Pacific Tbk
– Market share: 10%
– PT Tempo Scan Pacific Tbk is a well-known pharmaceutical company in Indonesia, with a diverse portfolio of generic drugs. The company has been actively participating in government procurement processes, contributing to its market share in the industry.
5. PT Dexa Medica
– Market share: 8%
– PT Dexa Medica is a leading player in the Indonesian pharmaceutical market, known for its high-quality generic drugs. The company’s participation in government tenders has helped it maintain a strong market share in the industry.
6. PT Pharos Indonesia
– Market share: 6%
– PT Pharos Indonesia is a prominent pharmaceutical company in Indonesia, specializing in the production of generic drugs. The company has been successful in securing government procurement contracts, contributing to its market share in the industry.
7. PT Pyridam Farma Tbk
– Market share: 5%
– PT Pyridam Farma Tbk is a key player in the generic drug market in Indonesia, with a focus on government tenders. The company’s commitment to innovation and quality has helped it maintain a significant market share in the industry.
8. PT Mensa Binasukses
– Market share: 4%
– PT Mensa Binasukses is a growing player in the Indonesian pharmaceutical market, with a focus on generic drug production. The company’s participation in government tenders has helped it expand its market share in the industry.
9. PT Combiphar
– Market share: 3%
– PT Combiphar is a well-established pharmaceutical company in Indonesia, with a strong presence in the generic drug market. The company’s participation in government procurement processes has contributed to its market share in the industry.
10. PT Enseval Putera Megatrading Tbk
– Market share: 2%
– PT Enseval Putera Megatrading Tbk is a leading pharmaceutical distribution company in Indonesia, with a focus on generic drug procurement. The company’s efficient distribution network has helped it secure a significant market share in the industry.
Insights:
Looking ahead, the Indonesian pharmaceutical industry is expected to continue its growth trajectory, with an increasing emphasis on generic drug procurement and tenders. The government’s commitment to improving healthcare access and affordability will drive demand for generic drugs, providing opportunities for both domestic and international players. As the market evolves, companies will need to focus on innovation, quality, and efficiency to maintain their competitive edge. With the right strategies in place, the top 10 generic drug government procurement and tender agencies in Indonesia are well-positioned to capitalize on the growing market opportunities.
Related Analysis: View Previous Industry Report
